Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Gold Town Games | GTG | Nov 21, 2024 | 0.14 | -10.19 |
Gomero Group | GOMERO | Nov 21, 2024 | 17.65 | -4.08 |
GomSpace Group | GOMX | Nov 21, 2024 | 4.39 | +5.91 |
Goobit Group | BTCX | Nov 21, 2024 | 0.15 | -5.81 |
Goodbye Kansas Group | GBK | Nov 21, 2024 | 1.38 | 0.00 |
Gosol Energy Group AB | GOSOL | Nov 21, 2024 | 1.18 | +1.90 |
Greater Than | GREAT | Nov 21, 2024 | 31.20 | 0.00 |
Green Landscaping Group | GREEN | Nov 21, 2024 | 71.50 | +0.14 |
Greenmerc | GMERCB | Nov 21, 2024 | 7.28 | -0.82 |
Gruvaktiebolaget Viscaria | VISC | Nov 21, 2024 | 21.75 | -1.58 |
Gränges | GRNG | Nov 21, 2024 | 118.40 | -1.74 |
Grängesberg Exploration Holding | GRANGX | Nov 21, 2024 | 8.77 | +0.11 |
Guard Therapeutics International | GUARD | Nov 21, 2024 | 20.20 | 0.00 |
Guideline Geo | GGEO | Nov 21, 2024 | 7.84 | 0.00 |
Gullberg & Jansson | GJAB | Nov 21, 2024 | 15.30 | -1.29 |
H&D Wireless Sweden Holding B | HDWB | Nov 21, 2024 | 0.00 | 0.00 |
H&M B | HMB | Nov 21, 2024 | 153.55 | +0.36 |
HAKI Safety A | HAKIA | Nov 21, 2024 | 27.00 | 0.00 |
HAKI Safety B | HAKIB | Nov 21, 2024 | 25.40 | -1.55 |
Hamlet BioPharma AB (publ) | HAMLETB | Nov 21, 2024 | 2.68 | -5.63 |
Hansa Biopharma | HNSA | Nov 21, 2024 | 29.88 | -2.35 |
Hanza AB | HANZA | Nov 21, 2024 | 65.55 | +0.15 |
Harm Reduction Group | NOHARM | Nov 21, 2024 | 0.05 | +4.00 |
Havsfrun Investment | HAVS | Nov 21, 2024 | 13.10 | +3.97 |
Havsfrun Investment B | HAVB | Nov 21, 2024 | 13.10 | +3.97 |
Haypp Group | HAYPP | Nov 21, 2024 | 59.80 | -2.29 |
Headsent | VIMAB | Nov 21, 2024 | 7.75 | -3.73 |
Heba B | HEBAB | Nov 21, 2024 | 30.60 | -0.65 |
Hedera Group | HEGR | Nov 21, 2024 | 2.50 | -4.58 |
Heimstaden Pref | HEIMPREF | Nov 21, 2024 | 14.46 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.